Literature DB >> 16443227

The course of infections and pathology in immunomodulated NOD/LtSz-SCID mice inoculated with Plasmodium falciparum laboratory lines and clinical isolates.

Alicia Moreno1, Elizabeth Ferrer, Susana Arahuetes, Cesar Eguiluz, Nico Van Rooijen, Agustin Benito.   

Abstract

Human chimeras are potentially invaluable models for hemoprotozoan parasites such as Plasmodium falciparum. The work presented assesses the susceptibility of immunomodulated NOD/LtSz-SCID mice to genetically distinct P. falciparum parasites. To this end, mice grafted with human erythrocytes were inoculated with two P. falciparum laboratory lines, 3D7 and Dd2 and four clinical isolates, ISCIII-230, ISCIII-231, ISCIII-381 and ISCIII-399. The results showed that, without a previous period of parasite adaptation, 100% of the inoculated mice developed an infection, generally self-limited, though some mice died. The parasitemias ranged from 0.05 to 8% and lasted an average of 19 days (15-26 days) depending on the line or isolate studied. Sexual forms of different maturity, stage II-IV and mature gametocytes were observed in the peripheral blood of mice in 22, 50, 25, 72 and 80% of the mice infected with Dd2, ISCIII-399, ISCIII-230, ISCIII-231 and ISCIII-381 isolates, respectively. The study of the clinical symptoms, the haematological parameters and the histopathological changes in the infected mice showed that most of the malaria features were present in the infected mice except that the sequestration of infected erythrocytes was absent or at most a minor phenomenon, as also indicated by the presence of mature forms of the parasites in the peripheral blood. This study shows that the human chimeras allow the complete asexual and sexual erythrocytic cycle of different P. falciparum lines and clinical isolates to be observed in vivo. It opens a new way to investigate any parasite population in terms of infectivity, transmission, and drug resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16443227     DOI: 10.1016/j.ijpara.2005.10.012

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  11 in total

Review 1.  A pre-emptive strike against malaria's stealthy hepatic forms.

Authors:  Dominique Mazier; Laurent Rénia; Georges Snounou
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

2.  Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes.

Authors:  María Belén Jiménez-Díaz; Teresa Mulet; Sara Viera; Vanessa Gómez; Helen Garuti; Javier Ibáñez; Angela Alvarez-Doval; Leonard D Shultz; Antonio Martínez; Domingo Gargallo-Viola; Iñigo Angulo-Barturen
Journal:  Antimicrob Agents Chemother       Date:  2009-07-13       Impact factor: 5.191

3.  Selection of a trioxaquine as an antimalarial drug candidate.

Authors:  Frédéric Coslédan; Laurent Fraisse; Alain Pellet; François Guillou; Benjamin Mordmüller; Peter G Kremsner; Alicia Moreno; Dominique Mazier; Jean-Pierre Maffrand; Bernard Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

4.  Analysis of innate defences against Plasmodium falciparum in immunodeficient mice.

Authors:  Ludovic Arnold; Rajeev Kumar Tyagi; Pedro Mejia; Nico Van Rooijen; Jean-Louis Pérignon; Pierre Druilhe
Journal:  Malar J       Date:  2010-07-09       Impact factor: 2.979

5.  Further improvements of the P. falciparum humanized mouse model.

Authors:  Ludovic Arnold; Rajeev Kumar Tyagi; Pedro Meija; Claire Swetman; James Gleeson; Jean-Louis Pérignon; Pierre Druilhe
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

6.  De Novo Generated Human Red Blood Cells in Humanized Mice Support Plasmodium falciparum Infection.

Authors:  Anburaj Amaladoss; Qingfeng Chen; Min Liu; Sara K Dummler; Ming Dao; Subra Suresh; Jianzhu Chen; Peter R Preiser
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

7.  Plasmodium falciparum full life cycle and Plasmodium ovale liver stages in humanized mice.

Authors:  Valérie Soulard; Henriette Bosson-Vanga; Audrey Lorthiois; Clémentine Roucher; Jean-François Franetich; Gigliola Zanghi; Mallaury Bordessoulles; Maurel Tefit; Marc Thellier; Serban Morosan; Gilles Le Naour; Frédérique Capron; Hiroshi Suemizu; Georges Snounou; Alicia Moreno-Sabater; Dominique Mazier
Journal:  Nat Commun       Date:  2015-07-24       Impact factor: 14.919

8.  A humanized mouse model for sequestration of Plasmodium falciparum sexual stages and in vivo evaluation of gametocytidal drugs.

Authors:  Yoann Duffier; Audrey Lorthiois; Pau Cisteró; Florian Dupuy; Grégory Jouvion; Laurence Fiette; Dominique Mazier; Alfredo Mayor; Catherine Lavazec; Alicia Moreno Sabater
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

9.  A humanized mouse model of tuberculosis.

Authors:  Veronica E Calderon; Gustavo Valbuena; Yenny Goez; Barbara M Judy; Matthew B Huante; Putri Sutjita; R Katie Johnston; D Mark Estes; Robert L Hunter; Jeffrey K Actor; Jeffrey D Cirillo; Janice J Endsley
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

10.  A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes.

Authors:  Iñigo Angulo-Barturen; María Belén Jiménez-Díaz; Teresa Mulet; Joaquín Rullas; Esperanza Herreros; Santiago Ferrer; Elena Jiménez; Alfonso Mendoza; Javier Regadera; Philip J Rosenthal; Ian Bathurst; David L Pompliano; Federico Gómez de las Heras; Domingo Gargallo-Viola
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.